Home > News content

Moderna may conduct the first clinical trial of a vaccine against the mutated new coronavirus next week

via:3DMGame     time:2021/3/7 12:41:22     readed:224

As early as next week, Moderna will start its first clinical trial of a new crown candidate vaccine against the mutant virus. The experiment will be conducted at five research sites in the United States.The main purpose of this study was to evaluate the safety and efficacy of mrna-1273 and mrna-1273.351 vaccines, and the secondary purpose was to evaluate the antibody mediated immunity of mrna-1273 and mrna-1273.351 vaccines.

It is understood that Moderna announced in February that it has completed the clinical trial dose manufacturing of specific candidate vaccine mrna-1273.351 for b.1.351 (also known as 501y.v2) new coronal mutant virus first found in South Africa.

The company recently said it had agreed to supply 13 million doses of the vaccine to the Philippine government, starting in mid-2021. The company is also expected to reach a separate agreement with the Philippine government and the private sector to provide another 7 million doses of vaccine.

China IT News APP

Download China IT News APP

Please rate this news

The average score will be displayed after you score.

Post comment

Do not see clearly? Click for a new code.

User comments